Stereotactic radiosurgery for optic nerve sheath meningiomas: A comprehensive systematic review and meta-analysis
- PMID: 40580760
- DOI: 10.1016/j.jocn.2025.111432
Stereotactic radiosurgery for optic nerve sheath meningiomas: A comprehensive systematic review and meta-analysis
Abstract
Background: Optic nerve sheath meningiomas (ONSMs) are rare brain neoplastic lesions that account for 2% of meningiomas. Despite the benign and slow-growing behavior of ONSMs, these lesions can result in irreversible blindness. Radiotherapy (RT) is one of the main therapeutic options for the management of ONSMs. Stereotactic radiosurgery (SRS) has demonstrated favorable outcomes in patients with ONSMs. This systematic review and meta-analysis aimed to evaluate local control (LC), preservation of visual field (VF)/visual acuity (VA), and radiation-induced neuropathy/retinopathy.
Methods: On March 17, 2025, four electronic databases, PubMed, Embase, Scopus, and Web of Science, were searched. Studies that evaluated the efficacy and safety of SRS in ONSMs were included.
Results: Seven studies involving 149 patients were included. The mean follow-up duration ranged from 30 to 116.86 months. The meta-analysis reported a pooled LC rate of 95 % (95 % CI: 90 %-98 %). The pooled estimates for VA and VF preservation were 91 % (95 % CI: 76 %-100 %) and 94 % (95 % CI: 68 %-100 %), respectively. Additionally, the meta-analysis found a pooled radiation-induced neuropathy/retinopathy rate of 0 % (95 % CI: 0 %-3%).
Conclusion: SRS demonstrated promising clinical and radiological outcomes in patients with ONSMs. SRS has comparable results to those of the other RT modalities. Further studies with large sample sizes are required to compare SRS and RT modalities.
Keywords: Cyberknife; Gamma knife; Meningioma; Meta-analysis; Optic Nerve; Optic nerve sheath; Radiosurgery.
Copyright © 2025 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Hypofractionated Radiosurgery (25 Gy/5 Fractions) for Optic Nerve Sheath Meningiomas: Results From an Exploratory Phase 2 Prospective Trial.Int J Radiat Oncol Biol Phys. 2025 Oct 1;123(2):406-414. doi: 10.1016/j.ijrobp.2025.04.038. Epub 2025 May 9. Int J Radiat Oncol Biol Phys. 2025. PMID: 40349855 Clinical Trial.
-
Efficacy and safety of stereotactic radiosurgery for large meningiomas: A comprehensive systematic review and meta-analysis.J Clin Neurosci. 2025 Aug;138:111384. doi: 10.1016/j.jocn.2025.111384. Epub 2025 Jun 11. J Clin Neurosci. 2025. PMID: 40505253 Review.
-
Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.Neurosurg Rev. 2023 Mar 17;46(1):71. doi: 10.1007/s10143-023-01969-7. Neurosurg Rev. 2023. PMID: 36928326
-
Efficacy and safety of stereotactic radiosurgery for foramen magnum meningiomas: a systematic review and meta-analysis.J Neurosurg Sci. 2025 Aug;69(4):341-349. doi: 10.23736/S0390-5616.25.06514-2. J Neurosurg Sci. 2025. PMID: 40662245
-
Upfront stereotactic radiosurgery versus adjuvant radiosurgery for parasagittal and parafalcine meningiomas: a systematic review and meta-analysis.Neurosurg Rev. 2024 Mar 22;47(1):127. doi: 10.1007/s10143-024-02360-w. Neurosurg Rev. 2024. PMID: 38514580
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources